NPY and depressive symptom measurement: The existence of resilient phenotypes has been proposed, which constitute the expression of genes determined and specific polymorphisms that regulate the functioning of the HPA axis, neuropeptide Y, and the noradrenergic, dopaminergic, and serotonergic systems [47] that, together with the autonomic nervous system, increase the likelihood of vulnerability to depression and other psychiatric disorders [52].